Gardenia jasminoides has therapeutic effects on L‑NNA‑induced hypertension in vivo

Chen,Shaocheng; Sun,Peng; Zhao,Xin; Yi,Ruokun; Qian,Jun; Shi,Yanhong; Wang,Rui

doi:10.3892/mmr.2017.6542

Gardenia jasminoides has therapeutic effects on L‑NNA‑induced hypertension in vivo

Authors:
- Shaocheng Chen
- Peng Sun
- Xin Zhao
- Ruokun Yi
- Jun Qian
- Yanhong Shi
- Rui Wang
View Affiliations

Affiliations: Chongqing Collaborative Innovation Center for Functional Food, Chongqing University of Education, Chongqing 400067, P.R. China, School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201210, P.R. China
Published online on: May 2, 2017 https://doi.org/10.3892/mmr.2017.6542
Pages: 4360-4373

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gardenia jasminoides is a plant that has been used in traditional Chinese medicine. It has four key active components (genipin gentiobioside, geniposide, crocin 1 and crocin 2). The aim of the present study was to determine the anti‑hypertension effects of Gardenia jasminoidesin vivo. The chemical composition of Gardenia jasminoides was determined using liquid chromatography. The anti‑hypertensive effects of Gardenia jasminoides were determined by a L‑NG‑nitroarginine (L‑NNA)‑induced hypertension animal model. Both Gardenia jasminoides plants of the Jiangjin County variety (CJGJ) and the Lichuan City variety (HLGJ) were used. HLGJ contained more geniposide than CJGJ. L‑NNA was used to induce hypertension in mice, and the mice were subsequently treated with CJGJ and HLGJ. The Gardenia jasminoides‑treated mice exhibited lower systolic (SBP), diastolic (DBP) and mean blood pressure (MBP) than the experimental control mice. Additionally, HLGL has a more potent effect on SBP, MBP and DBP than CJGJ. Following Gardenia jasminoides treatment, the nitric oxide contents in serum, heart, liver, kidney and stomach of mice were higher than the L‑NNA‑induced control mice, and the malondialdehyde contents were lower; the levels in HLGJ‑treated mice were closer to those normal mice than the levels in CJGJ‑treated mice were. Serum levels of endothelin‑1 and vascular endothelial growth factor were reduced by HLGJ treatment in hypertensive mice, whereas the calcitonin gene‑related peptide level was raised. Reverse transcription‑polymerase chain reaction analysis of mouse heart and vessel tissue demonstrated that HLGJ‑treated mice exhibited higher heme oxygenase‑1, neuronal nitric oxide synthase (nNOS), endothelial NOS, Bax, caspase‑3, caspase‑8, caspase‑9 mRNA expression levels and lower adrenomedullin, receptor activity modifying protein, interleukin‑1β, tumor necrosis factor‑α, inducible NOS, Bcl‑2, monocyte chemoattractant protein‑1, nuclear factor‑κB and matrix metalloproteinase‑2 and ‑9 mRNA expression compared with control hypertensive mice and CJGJ‑treated mice. In conclusion, Gardenia jasminoides has anti‑hypertensive effects, and these effects may be associated with the active component, geniposide.

View Figures

View References

1	Gu WL, Shi ZX, Yu YX, Wu YW, Lu BW and Hui KK: Distribution characteristics of syndrome types in essential hypertension. Zhong Xi Yi Jie He Xue Bao. 8:842–847. 2010.(In Chinese). View Article : Google Scholar
2	Xu HY and Wang YQ: Investigation and application for the therapy of hypertension with traditional Chinese medicine. China Prac Med. 3:189–192. 2008.(In Chinese).
3	Shen CZ, Peng MC, Kuang HR and Cheng ZQ: The effect of Chinese food therapy on the quality of life in patients with hypertension. Chin J Nurs. 44:510–513. 2009.(In Chinese).
4	Jiang CX, Cheng JG and Luo T: Nutritional value analysis of medicinal and edible plant. J Anhui Agri Sci. 43:282–284. 2015.
5	Meng XL, Li HW, Li Y, Yu Q, Wan LL and Guo C: Advances in Studies on chemical constituents and pharmacological activities of Gardenia jasminoides. Chinese J New Drug. 20:959–967. 2011.
6	Chen H, Xiao YQ, Li L and Zhang C: Studies on chemical constituents in fruit of Gardenia jasminoides. Zhongguo Zhong Yao Za Zhi. 32:1041–1043. 2007.(In Chinese).
7	Chen SC, Shi HY, Yang N and Wang R: Comparison of main effective constituent content of Gardenia jasminoides in Chongqing Hou-shan and other domestic areas. China J Exp Tradit Med Formulae. 18:131–134. 2012.(In Chinese).
8	Thomsen K, Rubin I and Lauritzen M: NO- and non-NO-, non-prostanoid-dependent vasodilatation in rat sciatic nerve during maturation and developing experimental diabetic neuropathy. J Physiol. 543:977–993. 2002. View Article : Google Scholar :
9	Gangula P, Ravella K, Chukkapalli S, Rivera M, Srinivasan S, Hale A, Channon K, Southerland J and Kesavalu L: Polybacterial periodontal pathogens alter vascular and gut BH4/nNOS/NRF2-phase II enzyme expression. PLoS One. 10:e01298852015. View Article : Google Scholar :
10	Simmonds MJ, Detterich JA and Connes P: Nitric oxide, vasodilation and the red blood cell. Biorheology. 51:121–134. 2014.
11	Zhao X, Wang Q, Li J, Chen F, Qian Y and Wang R: In vitro antioxidant, anti-mutagenic, anti-cancer and anti-angiogenic effects of Chinese Bowl tea. J Funct Food. 7:590–598. 2014. View Article : Google Scholar
12	Silva I, Teixeira A, Oliveira J, Almeida I, Almeida R and Vasconcelos C: Predictive value of vascular disease biomarkers for digital ulcers in systemic sclerosis patients. Clin Exp Rheumatol. 33(4 Suppl 91): S127–S130. 2015.
13	Gu X, Li H, Zhu X, Gu H, Chen J, Wang L, Harding P and Xu W: Inverse correlation between plasma adropin and ET-1 levels in essential hypertension: A cross-sectional study. Medicine (Baltimore). 94:e17122015. View Article : Google Scholar :
14	Li X, Qiu J, Pan M, Zheng D, Su Y, Wei M, Kong X, Sun W and Zhu J: Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1. Int J Clin Exp Pathol. 8:10743–10751. 2015.
15	Renga B, Cipriani S, Carino A, Simonetti M, Zampella A and Fiorucci S: Reversal of endothelial dysfunction by GPBAR1 agonism in portal hypertension involves a AKT/FOXOA1 dependent regulation of H2S generation and endothelin-1. PLoS One. 10:e01410822015. View Article : Google Scholar :
16	Feng EZ, Yang SY, Huang NX, Yin H, Zhang Y and Tian ZX: Plasma endothelin-1 and nitric oxide correlate with ligustrazine alleviation of pulmonary artery hypertension in patients of chronic corpulmonale from high altitude plateau during acute exacerbation. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 30:532–527. 2014.
17	Basralı F, Nasırcılar Ülker S, Koçer G, Ülker Karadamar P, Özyurt D, Cengiz M and Şentürk ÜK: Effect of magnesium on vascular reactivity in NOS inhibition-induced hypertension. Magnes Res. 28:64–74. 2015.
18	Nieto CI, Cabildo MP, Cornago MP, Sanz D, Claramunt RM, Torralba MC, Torres MR, Elguero J, García JA, López A, et al: Fluorination effects on NOS inhibitory activity of pyrazoles related to curcumin. Molecules. 20:15643–15665. 2015. View Article : Google Scholar
19	Kubes P and McCafferty DM: Nitric oxide and intestinal inflammation. Am J Med. 109:150–158. 2000. View Article : Google Scholar
20	Posa A, Pavo N, Hemetsberger R, Csonka C, Csont T, Ferdinandy P, Petrási Z, Varga C, Pavo IJ, Laszlo F Jr, et al: Protective effect of ischaemic preconditioning on ischaemia/reperfusion-induced microvascular obstruction determined by on-line measurements of coronary pressure and blood flow in pigs. Thromb Haemost. 103:450–460. 2010. View Article : Google Scholar
21	Huang HC, Wang SS, Chang CC, Lee FY, Lin HC, Hou MC, Teng TH, Chen YC and Lee SD: Evolution of portal-systemic collateral vasopressin response in endotoxemic portal hypertensive rats. Shock. 32:503–508. 2009. View Article : Google Scholar
22	Pulgar VM, Yamaleyeva LM, Varagic J, McGee C, Bader M, Dechend R and Brosnihan KB: Functional changes in the uterine artery precede the hypertensive phenotype in a transgenic model of hypertensive pregnancy. Am J Physiol Endocrinol Metab. 309:E811–E817. 2015. View Article : Google Scholar :
23	Theodorakis NG, Wang YN, Korshunov VA, Maluccio MA and Skill NJ: Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure. World J Gastroenterol. 21:4126–4135. 2015. View Article : Google Scholar :
24	Le Hiress M, Tu L, Ricard N, Phan C, Thuillet R, Fadel E, Dorfmüller P, Montani D, de Man F, Humbert M, et al: Proinflammatory signature of the dysfunctional endothelium in pulmonary hypertension. role of the macrophage migration inhibitory factor/CD74 complex. Am J Respir Crit Care Med. 192:983–997. 2015. View Article : Google Scholar
25	Zhang JL, Qin YW, Zheng X, Qiu JL, Zhang LZ, Zhang JR and Bian JL: Relevance of serum soluble E-selectin level and blood pressure in hypertensive patients. Shanghai Med J. 27:7–9. 2004.
26	Chen J and Li J: Clinical curative effect and influence on E-selectin, iNOS, eNOS in patient of essential hypertension with massotherapy. China J Tradit Chinese Med Pharm. 25:1708–1710. 2010.
27	Calò LA, Dal Maso L, Pagnin E, Ravarotto V, Facco M, Boscaro E, Maiolino G, Pessina AC and Rossi GP: Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients. J Hypertens. 32:193–199. 2014. View Article : Google Scholar
28	Wang ZG, Liu JL, Liu Y, Wen SJ, Wen J, Liu YP, Chen XJ and Wu ZS: Increased plasma vasoactive substances and antioxidant enzymes levels in prehypertensive patients. Zhonghua Xin Xue Guan Bing Za Zhi. 35:719–722. 2007.(In Chinese).
29	Nakamura M, Han B, Nunobiki O and Kakudo K: Adrenomedullin: A tumor progression factor via angiogenic control. Curr Cancer Drug Targets. 6:635–643. 2006. View Article : Google Scholar
30	Liu K, Deng X, Gong L, Chen X, Wang S, Chen H, Chen X, Amrit B and He S: The effect of intermedin on angiotensin II and endothelin-1 induced ventricular myocyte hypertrophy in neonatal rat. Clin Lab. 59:589–596. 2013. View Article : Google Scholar
31	Sumimoto T, Nishikimi T, Mukai M, Matsuzaki K, Murakami E, Takishita S, Miyata A, Matsuo H and Kangawa K: Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension. Hypertension. 30:741–745. 1997. View Article : Google Scholar
32	Oie E, Vinge LE, Yndestad A, Sandberg C, Grøgaard HK and Attramadal H: Induction of a myocardial adrenomedullin signaling system during ischemic heart failure in rats. Circulation. 101:415–422. 2000. View Article : Google Scholar
33	Sano M, Kuroi N, Nakayama T, Sato N, Izumi Y, Soma M and Kokubun S: Association study of calcitonin-receptor-like receptor gene in essential hypertension. Am J Hypertens. 18:403–408. 2005. View Article : Google Scholar
34	Gong YS, Fan XF, Wu XM, Hu LG, Tang CS, Pang YZ and Qi YF: Changes of intermedin/adrenomedullin 2 and its receptors in the right ventricle of rats with chronic hypoxic pulmonary hypertension. Sheng Li Xue Bao. 59:210–214. 2007.(In Chinese).
35	Jian L, Fa X, Zhou Z and Liu S: Functional analysis of UMOD gene and its effect on inflammatory cytokines in serum of essential hypertension patients. Int J Clin Exp Pathol. 8:11356–11363. 2015.
36	Good RB, Gilbane AJ, Trinder SL, Denton CP, Coghlan G, Abraham DJ and Holmes AM: Endothelial to mesenchymal transition contributes to endothelial dysfunction in pulmonary arterial hypertension. Am J Pathol. 185:1850–1858. 2015. View Article : Google Scholar
37	Manhiani MM, Seth DM, Banes-Berceli AK, Satou R, Navar LG and Brands MW: The role of IL-6 in the physiologic versus hypertensive blood pressure actions of angiotensin II. Physiol Rep. 3:pii: e125952015. View Article : Google Scholar
38	Serban D, Leng J and Cheresh D: H-ras regulates angiogenesis and vascular permeability by activation of distinct downstream effectors. Circ Res. 102:1350–1358. 2008. View Article : Google Scholar :
39	Muti LA, Pârvu AE, Crăciun AM, Miron N and Acalovschi M: Nitro-oxidative stress, VEGF and MMP-9 in patients with cirrhotic and non-cirrhotic portal hypertension. Clujul Med. 88:140–145. 2015. View Article : Google Scholar :
40	Minarchick VC, Stapleton PA, Sabolsky EM and Nurkiewicz TR: Cerium dioxide nanoparticle exposure improves microvascular dysfunction and reduces oxidative stress in spontaneously hypertensive rats. Front Physiol. 6:3392015. View Article : Google Scholar :
41	Zhou Y, Zhao L, Zhang Z and Lu X: Protective effect of enalapril against methionine-enriched diet-induced hypertension: Role of endoplasmic reticulum and oxidative stress. Biomed Res Int. 2015:7248762015. View Article : Google Scholar :
42	Zhang S, Yang T, Xu X, Wang M, Zhong L, Yang Y, Zhai Z, Xiao F and Wang C: Oxidative stress and nitric oxide signaling related biomarkers in patients with pulmonary hypertension: A case control study. BMC Pulm Med. 15:502015. View Article : Google Scholar :
43	Pérez-de-Puig I, Martín A, Gorina R, de la Rosa X, Martinez E and Planas AM: Induction of hemeoxygenase-1 expression after inhibition of hemeoxygenase activity promotes inflammation and worsens ischemic brain damage in mice. Neuroscience. 243:22–32. 2013. View Article : Google Scholar
44	He M, Nitti M, Piras S, Furfaro A, Traverso N, Pronzato MA and Mann GE: Heme oxygenase-1-derived bilirubin protects endothelial cells against high glucose-induced damage. Free Radic Biol Med. 89:91–98. 2015. View Article : Google Scholar
45	Chao HM, Chuang MJ, Liu JH, Liu XQ, Ho LK, Pan WH, Zhang XM, Liu CM, Tsai SK, Kong CW, et al: Baicalein protects against retinal ischemia by antioxidation, antiapoptosis, downregulation of HIF-1α, VEGF, and MMP-9 and upregulation of HO-1. J Ocul Pharmacol Ther. 29:539–549. 2013. View Article : Google Scholar :
46	Li Z, Wang Y, Man RY and Vanhoutte PM: Upregulation of heme oxygenase-1 potentiates EDH-type relaxations in the mesenteric artery of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol. 305:H1471–H1483. 2013. View Article : Google Scholar
47	Imenshahidi M, Hosseinzadeh H and Javadpour Y: Hypotensive effect of aqueous saffron extract (Crocus sativus L.) and its constituents, safranal and crocin, in normotensive and hypertensive rats. Phytother Res. 24:990–994. 2010.
48	Xu GL, Qian ZY, Yu SQ, Gong ZN and Shen XC: Evidence of crocin against endothelial injury induced by hydrogen peroxide in vitro. J Asian Nat Prod Res. 8:79–85. 2006. View Article : Google Scholar
49	Chen L, Luo ZK, Peng GP, Li XH, Liu L, Sheng XB and Wang ZG: The cardiac systolic and diastolic effects of genipin-1-β-D-gentiobioside in the experimental heart failure. Pharm Clin Chinese Mater Med. 29:39–41. 2013.(In Chinese).
50	Wang ZC, Yang XL, Zhang K and Xiao P: Research on pharmacological activities of gardenoside. J Henan Univ Sci Technol Med Sci. 30:159–160. 2012.
51	Pang H, Han B, Yu T and Peng Z: The complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophy. PLoS One. 9:e922162014. View Article : Google Scholar :
52	Wang HT, Liu CF, Tsai TH, Chen YL, Chang HW, Tsai CY, Leu S, Zhen YY, Chai HT, Chung SY, et al: Effect of obesity reduction on preservation of heart function and attenuation of left ventricular remodeling, oxidative stress and inflammation in obese mice. J Transl Med. 10:1452012. View Article : Google Scholar :
53	Kolwicz SC, MacDonnell SM, Renna BF, Reger PO, Seqqat R, Rafiq K, Kendrick ZV, Houser SR, Sabri A and Libonati JR: Left ventricular remodeling with exercise in hypertension. Am J Physiol Heart Circ Physiol. 297:H1361–H1368. 2009. View Article : Google Scholar :
54	Favaloro B, Allocati N, Graziano V, Di Ilio C and De Laurenzi V: Role of apoptosis in disease. Aging (Albany NY). 4:330–349. 2012. View Article : Google Scholar :
55	Liu Y, Wang S, Wang C, Song H, Han H, Hang P, Jiang Y, Wei L, Huo R, Sun L, et al: Upregulation of M3 muscarinic receptor inhibits cardiac hypertrophy induced by angiotensin II. J Transl Med. 11:2092013. View Article : Google Scholar :
56	Shi XC, Liu W, Wang J and Zhao YQ: Effect of the Tianma Gouteng regulating the protein expression of Bax and Caspase-3 of myocardial tissue in spontaneously hypertensive rats. Tianjin J Tradi Chinese Med. 33:354–357, (In Chinese).
57	Jing X, Chen SS, Jing W, Tan Q, Yu MX and Tu JC: Diagnostic potential of differentially expressed homer1, IL-1β, and TNF-α in coronary artery disease. Int J Mol Sci. 16:535–546. 2014. View Article : Google Scholar :
58	Zhu XY, Chade AR, Krier J, Daghini E, Lavi E, Guglielmotti A, Lerman A and Lerman LO: The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension. J Hypertens. 27:2063–2073. 2009. View Article : Google Scholar :
59	Fu L, Das B, Mathew S and Shi YB: Genome-wide identification of Xenopus matrix metalloproteinases: Conservation and unique duplications in amphibians. BMC Genomics. 10:812009. View Article : Google Scholar :
60	Raffetto JD and Khalil RA: Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol. 75:346–359. 2008. View Article : Google Scholar
61	Givvimani S, Munjal C, Tyagi N, Sen U, Metreveli N and Tyagi SC: Mitochondrial division/mitophagy inhibitor (mdivi) ameliorates pressure overload induced heart failure. PLoS One. 7:e323882012. View Article : Google Scholar :
62	Li W, Mata KM, Mazzuca MQ and Khalil RA: Altered matrix metalloproteinase-2 and −9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy. Biochem Pharmacol. 89:370–385. 2014. View Article : Google Scholar :
63	Kluknavsky M, Balis P, Puzserova A, Radosinska J, Berenyiova A, Drobna M, Lukac S, Muchova J and Bernatova I: (−)-Epicatechin prevents blood pressure increase and reduces locomotor hyperactivity in young spontaneously hypertensive rats. Oxid Med Cell Longev. 2016:69490202016. View Article : Google Scholar :
64	Belo VA, Parente JM, Tanus-Santos JE and Castro MM: Matrix metalloproteinase (MMP)-2 decreases calponin-1 levels and contributes to arterial remodeling in early hypertension. Biochem Pharmacol. 118:50–58. 2016. View Article : Google Scholar
65	Akinrinde AS, Oyagbemi AA, Omobowale TO, Asenuga ER and Ajibade TO: Alterations in blood pressure, antioxidant status and caspase 8 expression in cobalt chloride-induced cardio-renal dysfunction are reversed by Ocimum gratissimum and gallic acid in Wistar rats. J Trace Elem Med Biol. 36:27–37. 2016. View Article : Google Scholar